Genzyme has an on-going commitment to help provide access to Renvela® (sevelamer carbonate).
While many of you may have prescription benefits, for those of you who do not or whose prescription benefits are limited or require prior authorization, getting prescription drugs may be a challenge. To help you, Genzyme RenassistSM offers a variety of services that may make Renvela more accessible. Our dedicated team of Renassist Case Managers make the process easy. They can work with your social worker, dietitian or patient advocate to determine the type of assistance you need.
Your Renassist Case Manager along with your Social Worker can:
Verify your insurance coverage
Facilitate any prior authorizations
Research coverage of Renvela within specific plans
Educate you on Medicare Part D and other changes to Medicare
Submit your application to the American Kidney Fund to determine free-drug eligibility
These services are offered at no cost. Case Managers act in accordance with patient privacy regulations (HIPAA) to maintain patient confidentiality.
With just one phone call, Genzyme can help you gain access to Renvela. Talk to your social worker today.
Genzyme Renvela
Important Treatment Considerations
Renvela® (sevelamer carbonate) is used to control phosphorus levels in patients with chronic kidney disease (CKD) on dialysis
Do not use Renvela if you have a history of bowel obstruction
Talk to your doctor if you have had digestive tract surgery or other digestive disorders, including severe constipation
Uncommon cases of bowel obstruction and perforation have been reported
Your doctor should monitor bicarbonate and chloride blood levels • Vitamins D, E, K (clotting factors), and folic acid blood levels should also be monitored by your doctor
The most frequently occurring side effects observed with sevelamer carbonate tablets were nausea and vomiting
Side effects with sevelamer carbonate powder taken three times a day were similar to those reported for sevelamer carbonate tablets
The most common side effects with sevelamer hydrochloride, which contains the same active ingredient as sevelamer carbonate, included: vomiting, nausea, diarrhea, dyspepsia, abdominal pain, flatulence, and constipation
Cases of fecal impaction and, less commonly, ileus, bowel obstruction, and bowel perforation have been reported
Take Renvela with meals and adhere to your prescribed diet
Talk to your doctor when taking Renvela with other medications • Promptly contact your doctor if you experience severe abdominal pain, new or worsening constipation, or other severe intestinal symptoms while on Renvela
Genzyme Corporate
